
Opinion|Videos|June 9, 2025
The importance of studying efficacy and safety of treatment in Black patients with mHSPC
Author(s)Quoc-Dien Trinh, MD, MPH
Research highlights the need for personalized treatment in mHSPC, addressing variations in drug efficacy across diverse populations for optimal patient care.
Advertisement
Episodes in this series

Importance of Personalized Medicine
Key Themes:
- Drug efficacy and safety may vary across different subpopulations.
- Considerations extend beyond race to other demographic factors.
- There is a potential need for personalized dosing approaches.
- Targeted studies are crucial for clinician confidence and patient reassurance.
Key Points for Physicians:
- Consider individual characteristics beyond race when selecting treatments.
- Recognize the growing importance of personalized medicine approaches.
- Communicate clearly with patients about evidence supporting treatment recommendations.
Notable Insights: The discussion of personalized medicine extends beyond race to consider the broader landscape of individual variation in drug response and tolerability.
Clinical Significance: Advancing personalized medicine approaches, including subgroup-specific analyses, will improve cancer care by appropriately tailoring treatments to individual and population characteristics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5












